ABOUT
TEAM
STRATEGY
PORTFOLIO
NEWS
More
BioStar Capital invests in and nurtures transformative medical technologies. We have consistently produced life-changing outcomes for patients and rewarding returns for investors.
Transcatheter renal denervation for hypertension.
Pulsatile Intravascular Lithotripsy (PIVL) for calcified arteries.
Passive implant for treating pulmonary hypertension.
Catheter-based nerve sensing and ablation in a single procedure.
Robotically manufactured polymer heart valve.
Transcranial Magnetic Stimulation (TMS) for mental health.
Robotic microsurgery using NanoWrist instruments.
Endovascular therapy for stabilizing abdominal aortic aneurysms (AAA).
Handheld tear stimulation device for dry eye disease.
Bioresorbable polymer technologies for vascular applications.
Long-term continuous glucose monitoring for diabetes management.
Simple, percutaneous tricuspid valve repair without surgery.